Keiagrmed Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Net Worth -2439.15%
- Total Assets 179.95%
About Keiagrmed
Keiagrmed Private Limited (KPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 December 2018 (Six years and one month 16 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narasaiah Arigela and Anuspala Kamineni serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999TG2018PTC129037
- Company No.
129037
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Keiagrmed?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narasaiah Arigela  | Director | 02-Sep-2022 | Current |
| Anuspala Kamineni | Director | 14-Dec-2018 | Current |
Financial Performance of Keiagrmed.
Keiagrmed Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 2439.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Keiagrmed?
In 2020, Keiagrmed had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kerala First Health Services Private LimitedAnuspala Kamineni is a mutual person
Indian Hospitex Private LimitedNarasaiah Arigela is a mutual person
Manira Energy Private LimitedAnuspala Kamineni is a mutual person
New Viswabharathy Drug Lines Private LimitedNarasaiah Arigela is a mutual person
- Auspharma Private Limited
Narasaiah Arigela is a mutual person
- Guninaa Pharmaceuticals Private Limited
Narasaiah Arigela is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Keiagrmed?
Unlock and access historical data on people associated with Keiagrmed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Keiagrmed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Keiagrmed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
